Organization: Health Canada
Year: 2025
Month: February
Request Number: A-2024-000610
Request Summary: Adverse Drug Reactions (ADRs) for C1 Esterase Inhibitor (Human). Report numbers: E2B_07240241, E2B_07202397, E2B_07203738, E2B_07211715, E2B_07200893, E2B_07212141, 001091444. ADR for Mesalimine. Report number: 001097077. ADR for VYVANSE. Report number: 001092714. ADR for MEZAVANT. Report number: 001099893.
Disposition: Disclosed in part
Number of pages: 234